OR WAIT null SECS
January 29, 2024
The company issued the recall because of a package mislabeling problem.
January 17, 2024
The agency is reviewing data on secondary malignancies related to T-cells for approved CAR T-cell medicines.
January 15, 2024
The European Medicines Agency safety committee says there is a potential risk of neurodevelopment disorders in children born to men treated with valproate.
January 09, 2024
The potential for superpotent drug initiated the voluntary recall.
December 11, 2023
The product is being voluntarily recalled because of powder leakage due to seal integrity issues.
December 04, 2023
Novartis has issued a nationwide voluntary recall of two lots of Sandimmune Oral Solution (cyclosporine oral solution, USP), 100 mg/mL because of crystallization issues.
September 25, 2023
VistaPharm is recalling Sucralfate Oral Suspension, 1g/10mL because of Bacillus cereus contamination.
August 08, 2023
Lower levels of an active ingredient may result in unexpected pregnancies.
March 06, 2023
Any patients who have received the identified lots or have any questions regarding the recall should contact their pharmacy or immediately contact a health provider in terms of medical advice.
January 11, 2023
Epinephrine is a critical medication used during life-threatening conditions that can affect any age and any person.